Patent · US Active

Target sequences for synthetic molecules

US8133709B2 · kind B2 · utility

0Cited by
14References
23Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 3, 2008
Grant dateMar 13, 2012
Priority date
Expiry dateMar 29, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/532
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention is based on the discovery that certain biarsenical molecules react with specified target sequences, thereby providing a facile means for labeling polypeptides containing the target sequence. The invention is useful in creating stable mammalian cell lines expressing a certain tetracysteine tagged polypeptides, thereby overcoming toxicity associated with native tetracysteine. In addition, the invention allows for orthogonal labeling of polypeptides, thereby allowing for the observation of protein-protein interactions and conformational changes in proteins, for example.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.